Loading...
Loading...
Among the 5 tracked institutional investors we monitor, IONS 1.75 06/15/28 (IONIS PHARMACEUTICALS INC) is held with a combined value of $204.68M across 131,488,000 shares. The largest holder is CITADEL ADVISORS LLC with a position worth $134.72M (0.08% of their portfolio). 3 funds increased their holdings. 2 funds reduced their position.
Total Institutional Value
$204.68M
Total Shares Held
131,488,000
Institutional Holders
5
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | CITADEL ADVISORS LLC | $134.72M | 0.08% | +49.1% |
| 2 | STATE STREET CORP | $23.36M | 0.00% | +26.3% |
| 3 | WELLINGTON MANAGEMENT GROUP LLP | $17.96M | 0.00% | -16.6% |
| 4 | BlackRock, Inc. | $17.76M | 0.00% | -40.5% |
| 5 | FMR LLC | $10.89M | 0.00% | +0.2% |
As of the latest SEC 13F filings, CITADEL ADVISORS LLC is the largest institutional holder of IONS 1.75 06/15/28 with a position worth $134.72M, representing 0.08% of their portfolio. In total, 5 institutional investors hold IONS 1.75 06/15/28 with a combined value of $204.68M.
Institutional investors hold $204.68M worth of IONS 1.75 06/15/28 stock across 5 positions. The largest institutional holder is CITADEL ADVISORS LLC with $134.72M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For IONS 1.75 06/15/28, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their IONS 1.75 06/15/28 positions.